Jian Yu

Potent Anti-leukemia Activities of Chimeric Antigen Receptor–Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia

Yongxian Hu, Zhao Wu, Yi Luo et al. · Clinical Cancer Research · 2016 · 134 citations

Life Sciences, Oncology, Pharmacology +17

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study

Houli Zhao, Jieping Wei, Guoqing Wei et al. · Journal of Hematology & Oncology · 2020 · 83 citations · Full text

Medicine, Hematology, Oncology +16

Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

Yanmin Zhao, Fei Gao, Jimin Shi et al. · Biology of Blood and Marrow Transplantation · 2019 · 68 citations · Full text

Medicine, Hematology, Stem Cell Transplantation +13

Prognostic value of coagulation tests for in-hospital mortality in patients with traumatic brain injury

Qiang Yuan, Jian Yu, Xing Wu et al. · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · 2018 · 64 citations · Full text

Medicine, Neurological Surgery, Neurosurgery +13

Methylcap-Seq Reveals Novel DNA Methylation Markers for the Diagnosis and Recurrence Prediction of Bladder Cancer in a Chinese Population

Yangxing Zhao, Shicheng Guo, Jinfeng Sun et al. · PLoS ONE · 2012 · 63 citations · Full text

Medicine, Genetics, Oncology +17